Related resources and publications
Multispecific CD73/PD-1 targeting
Safety and activity of a conditionally active cLAG3-IL2
CD28xVISTA bispecific antibodies in immunotherapy
BRGSF-HIS & hFcγR to assess cell depletion
Novel PD-1 targeted IL-2Rβ/γ agonist
CD3 binding T-cell engagement
Humanized Mouse Model of Fcγ Receptors
CTLA-4 & survival in a colorectal cancer model
PD-1 & strong tumor growth inhibition
hPD-1 to evaluate novel cancer therapies
CD3 and BRGSF-HIS to assess IrAEs
Anti hCD39 to promote anti-tumor immunity
BRGSF-HIS & hVISTA for immunotherapies
BRGSF-HIS & CD3ε in CRS
hSTING & anti-tumor response in cold tumors
VISTA in the tumor microenvironment
anti-hVISTA against poorly immunogenic tumors
Theranostics
Eur J Nucl Med Mol Imaging
JCI Insight
JCI Insight
Mol Cancer Ther
Nat Commun
Hum Mol Genet
Front Immunol
Hear Res
Front Immunol
Front Immunol
Cell Mol Life Sci
J Thromb Haemost
J Allergy Clin Immunol
J Invest Dermatol
Immunohorizons
Proc Natl Acad Sci U S A
J Allergy Clin Immunol
PLoS One
Cell Rep
Acta Biomater
Nat Cancer
Prog Neurobiol
Int J Pharmac
Sci Rep
Mol Cancer
J Immunother Cancer
Neurobiol Dis
Matrix Biol
Pancreatology
Mol Cancer Ther
Nat Med
Cancer Discov
ACS Pharmacol Transl Sci
Proc Natl Acad Sci U S A
Bioconjug Chem
Cell Death Dis
Matrix Biol
Front Immunol
J Bone Miner Res
Nat Chem Biol
Nat Chem Biol
Sci Adv
Hum Genet
Cell
J Immunother Cancer
Eur J Microbiol Immunol
Invest Ophthalmol Vis Sci
J Alzheimers Dis
Cell Physiol Biochem
JCI Insight
EMBO J
PLoS One
J Biol Chem
PLoS One
Arterioscler Thromb Vasc Biol
J Control Release
Circ Res
Brain
Physiol Rep
J Bone Miner Res
J Am Heart Assoc
Blood
Cell Death Differ
J Neurosci
Cell Mol Life Sci
Diabetes
Humanized ICP in immuno-oncology
Immuno-oncolology models
Immuno-oncolology models
Humanized mouse models
T-cell engager
Assess toxicity with ICP
T-cell engager
Humanized PD-1 & GITR mouse
T-cell engager CD3
Assess T-cell engager in BRGSF-HIS
Humanized PD-1/PD-L1 mouse and cell line
Humanized HSA/hFcRn mouse
Humanized ICP mouse and cell lines
Assess T-cell engager in BRGSF-HIS
Humanized VISTA mouse & Pharmacokinetics
Humanized cLC model - Bispecific antibody development
Targeting the human CD47/SIRPα axis
BRGSF-HIS as model for acute implant-associated osteomyelitis
VISTA - safety and PK profiling
Therapeutic efficacy and pharmacokinetics
Physiological relevancy in preclinical models